In recent years, in order to further accelerate the pace of development and development of the new product, the company strengthened its cooperation with internationally renowned pharmaceutical companies and research institutions. In 2012, it signed the technology authorization and cooperation agreement with Taiwan Taijing Biological Technology Co., Ltd. and Taijing Biomedical Research and Development (Beijing) Co., Ltd. and obtained the exclusive patent license of the 1.1 class innovation medicine fluorine-free quinolone "nemonoxacin" within the territory of China. Its oral ...


At present, Zhejiang Medicine Co. Ltd. is specialized in the large-scale production of fat-soluble vitamins, quasi-vitamins, quino-lone antibiotics, anti-drug-resistant antibiot- ics and other products. Its output of vitamin E is the largest domestically, and the 2nd largest globally; the output of Vancomycin hydrochloride accounts for more than 40% of the global production.

飞艇计划全天免费软件网页版 上海时时信誉平台 重庆时时彩开奖视频直播 破解北京pk10冠亚和值 手机牛牛明牌抢庄规律 七乐彩玩法中奖规则 psv破解必玩中文神作 彩票冷热号规律 pk10免费永久计划app 黑马计划账号怎么注册 快乐时时计划 4张看牌抢庄技巧 足球看盘技巧 重庆肘时彩开奖号码 玩三分快三有导师带会赔吗 极速时时开奖统计表